![Liam Ratcliffe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Liam Ratcliffe
Direktor/Vorstandsmitglied bei
UPSTREAM BIO, INC.
Vermögen: - $ am 30.06.2026
Profil
Liam Ratcliffe currently works at Arvinas Operations, Inc., as Director from 2015, Halda Therapeutics LLC, as Director & Manager, Disc Medicine Opco, Inc., as Director from 2019, and various other companies.
Dr. Ratcliffe also formerly worked at Array BioPharma, Inc., as Independent Director from 2012 to 2014, Neuronetics, Inc., as Director, Zafgen, Inc., as Director, and various other companies.
Dr. Ratcliffe received his Masters Business Admin degree in 2006 from Stephen M.
Ross School of Business, doctorate degree in 1994 from the University of Cape Town, and undergraduate degree in 1987 from the University of Cape Town.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
UPSTREAM BIO, INC. -.--% | 09.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
-.--% | 04.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
DISC MEDICINE, INC. -.--% | 18.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Liam Ratcliffe
| Unternehmen | Position | Beginn |
|---|---|---|
| DISC MEDICINE, INC. | Direktor/Vorstandsmitglied | 01.09.2019 |
| UPSTREAM BIO, INC. | Direktor/Vorstandsmitglied | 01.10.2021 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Direktor/Vorstandsmitglied | 01.12.2019 |
Access Industries LLC
 Access Industries LLC Provides advancement of mobility technology | Corporate Officer/Principal | 01.04.2019 |
Disc Medicine Opco, Inc.
 Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Direktor/Vorstandsmitglied | 01.09.2019 |
Jamanda Ltd.
 Jamanda Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Direktor/Vorstandsmitglied | - |
Halda Therapeutics LLC
 Halda Therapeutics LLC BiotechnologyHealth Technology Operates as a a clinical-stage biotechnology company that has develops cancer therapeutics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Liam Ratcliffe
| Unternehmen | Position | Ende |
|---|---|---|
Halda Therapeutics OpCo, Inc.
 Halda Therapeutics OpCo, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops a mechanism and therapies for the treatment of cancers | Direktor/Vorstandsmitglied | 01.12.2025 |
| CLIMB BIO, INC. | Direktor/Vorstandsmitglied | 11.11.2024 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Liam Ratcliffe
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
34
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 34 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Neuronetics, Inc.
 Neuronetics, Inc. Medical SpecialtiesHealth Technology Develops and commercializes non-invasive therapies for psychiatric and neurological disorders | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Edge Therapeutics, Inc.
 Edge Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops therapies | Health Technology |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders | Health Technology |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Cogent Biosciences, Inc.
 Cogent Biosciences, Inc. BiotechnologyHealth Technology Discovers and develops new cellular immunotherapies for cancer | Health Technology |
Access Industries LLC
Access Industries LLC Provides advancement of mobility technology | |
University of Cape Town
 University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Health Technology |
Karus Therapeutics Ltd.
 Karus Therapeutics Ltd. BiotechnologyHealth Technology Provides therapies for treatment of cancer and inflammatory diseases | Health Technology |
New Leaf Venture Partners LLC
 New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements. | Finance |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops neuropathic pain products | Health Technology |
Calchan Holdings Ltd.
 Calchan Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops novel oral state-dependent calcium channel (CaV 2.2) modulators for chronic pain | Health Technology |
Calchan Ltd.
 Calchan Ltd. BiotechnologyHealth Technology Operates as a biotechnology company, which develops novel oral state dependent calcium channel modulators for chronic pain | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel treatments for psychiatric and neurodegenerative diseases | Health Technology |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Commercial Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
Halda Therapeutics LLC
Halda Therapeutics LLC BiotechnologyHealth Technology Operates as a a clinical-stage biotechnology company that has develops cancer therapeutics | Health Technology |
Access Biotechnology (Venture Capital)
 Access Biotechnology (Venture Capital) Investment ManagersFinance Access Biotechnology invests in both private and public companies located in the United States. The firm targets companies operating in the field of the biopharma companies. It provides financing for later stage transactions. | Finance |
Disc Medicine Opco, Inc.
Disc Medicine Opco, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for hematologic diseases | Commercial Services |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for dry age-related macular degeneration and associated rare genetic diseases | Health Technology |
Jamanda Ltd.
Jamanda Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Halda Therapeutics OpCo, Inc.
Halda Therapeutics OpCo, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops a mechanism and therapies for the treatment of cancers | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
